Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Adsorption Behavior of Methylene Blue, Cd<sup>2+</sup>, and Pb<sup>2+</sup> Onto Raw Bamboo Shoot Brown Powder: Kinetic, Isotherm, Thermodynamic, and Regeneration Studies.

Water environment research : a research publication of the Water Environment Federation·2026
Same author

Bioactive Anti-Inflammatory Compounds and Therapeutic Strategies for Promoting Resolution.

Pharmaceutics·2026
Same author

Correction: Mohite et al. Bioactive Compound-Fortified Nanomedicine in the Modulation of Reactive Oxygen Species and Enhancement of the Wound Healing Process: A Review. <i>Pharmaceutics</i> 2025, <i>17</i>, 855.

Pharmaceutics·2026
Same author

Tramadol-Induced Persistent Singultus: A Case Report on Diagnosis, Mechanism, and Management.

Clinical case reports·2026
Same author

Ethical and public health lessons from Ethiopia's first Marburg virus disease outbreak.

Journal of public health policy·2026
Same author

Fabrication of vesicle-incorporated etoposide-loaded nanocochleates for improved anticancer efficacy.

Naunyn-Schmiedeberg's archives of pharmacology·2026

相关实验视频

Updated: Sep 9, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.1K

重新定义遗传性卵巢癌的风险,生物标志物和精确疗法:一篇评论

Ambika Nand Jha1, Varsha Ratan Gaikwad2, Ashok Kumar Gupta1

  • 1School of Pharmacy, Sharda University, Greater Noida, Uttar Pradesh 201306, India.

ACS omega
|September 2, 2025
PubMed
概括

了解遗传性卵巢癌 (HOC) 涉及遗传易感性,特别是BRCA1/BRCA2突变. 风险评估,预防和PARP抑制剂的进展为这种致命的妇科恶性瘤提供了更好的结果.

更多相关视频

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

相关实验视频

Last Updated: Sep 9, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.1K
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

科学领域:

  • 癌症学
  • 遗传学
  • 流行病学

背景情况:

  • 遗传性卵巢癌 (HOC) 是一个严重的健康负担,
  • 在BRCA1和BRCA2基因中的致病性生殖基因突变是HOC的主要驱动因素.
  • 这些突变会损害DNA修复,导致基因组不稳定性和癌症风险增加.

研究的目的:

  • 审查遗传性卵巢癌的发展情况.
  • 专注于药物流行病学,风险评估,化疗预防和向治疗.
  • 完善临床决策和推进HOC的精密医学.

主要方法:

  • 关于遗传性卵巢癌的文献综述
  • 风险评估模型的分析 (BRCAPRO,BOADICEA).
  • 评估预防策略 (RRSO,化疗预防) 和向治疗 (PARP抑制剂).

主要成果:

  • 基因查有助于早期发现和预防HOC.
  • 降低风险的卵巢切除术和化疗预防减少了OC的发生率.
  • 在PARP抑制剂显著改善了HOC的无进展生存率.

结论:

  • 精准医疗方法正在彻底改变HOC的管理.
  • 针对性治疗,如PARP抑制剂对于同类重组缺陷瘤至关重要.
  • 持续的研究旨在改善遗传性卵巢癌患者的治疗结果.